Evolving Treatment Landscape in Transthyretin Cardiac Amyloidosis

Evolving Treatment Landscape in Transthyretin Cardiac Amyloidosis   Guest: Rosalyn Adigun, M.D., Pharm.D. Host: S. Allen Luis, M.B.B.S., Ph.D.   In this episode of Mayo Clinic’s “Interviews With the Experts,” Dr. Allen Luis interviews Dr. Rosalyn Adigun on transthyretin cardiac amyloidosis. Listeners will come away with a detailed overview of the evolution of treatment options for patient diagnosed with transthyretin amyloid cardiomyopathy, highlighting historical perspectives, early registration studies, current treatment options, and an outlook on future directions in the management of transthyretin cardiac amyloidosis.   Topics Discussed: Overview of the historical perspectives on the diagnosis and management of transthyretin amyloidosis. Current treatment options available for transthyretin amyloid cardiomyopathy, and factors that should guide a clinician's decision regarding the choice of therapy. Treatment options in the coming years. Ongoing research initiatives in the management of cardiac amyloidosis.    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.